Compumedics Limited (asx:cmp)business Update:sustainable, Profitable Performance 27th August 2010 - Views: 1435 Leading Australia-based medical device company, Compumedics Limited (ASX: CMP), is pleased to announce a net profit after tax of $0.5 million on revenues of $32.4 million for the year ended 30 June, 2010.
U.s. Government Grants Awarded For Further Development Of Adult Stem Cell Products 8th November 2010 - Views: 5694 Regenerative medicine company, Mesoblast Limited (ASX:MSB; USADR:MBLTY), today announced that its United States associate company, Angioblast Systems, has been awarded $1.2 million in grants under the United States Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Australian Couples Give Birth To A Generation Free Of The Psychological Burden 26th October 2010 - Views: 2154 Scientists call for wider awareness of Preimplantation Genetic Diagnosis for patients at high risk of passing breast cancer genes to their children.
Mesoblast Broadens Cancer Indications For Bone Marrow Transplant Product 14th October 2010 - Views: 2083 Australian regenerative medicine company Mesoblast Limited (ASX: MSB, USOTC: MBLTY) today announced that it is broadening the oncology applications of its "off-the-shelf" cell product for expansion of haematopoietic stem cells in patients with blood cancers.
Aussie Duo Breakthrough Weight Loss With Dna 13th October 2010 - Views: 2409 Mr. Matt Patti, Australia’s Exercise Professional of the Year and Mr. Paul Beaver a Doctor of Engineering are both long time devotees to finding the key to unlocking the secrets to achieving sustained health, energy and vitality for women across Australia.